Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 27, 2017

DrugPatentWatch Database Preview

Ondansetron - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ondansetron and what is the scope of ondansetron patent protection?

Ondansetron
is the generic ingredient in nine branded drugs marketed by Sun Pharm Inds Ltd, Chartwell Molecules, Teva, Nesher Pharms, Midatech Pharma Us, Mylan, Sandoz, Glenmark Generics, Sun Pharm Inds, Aurobindo Pharma, Novartis Pharms Corp, Barr, Aurobindo Pharma Ltd, Glaxosmithkline, Apotex, Taro, Qilu Pharm Co Ltd, West-ward Pharms Int, Pliva Hrvatska Doo, Taro Pharms Ireland, Lannett, Wockhardt, Emcure Pharms, Gland Pharma Ltd, Sandoz Inc, Luitpold, Hospira, Silarx, Apotex Inc, Mylan Labs Ltd, Accord Hlthcare, Emcure Pharms Ltd, Hikma Intl Pharms, Sun Pharm Inds (in), Natco Pharma Ltd, Fresenius Kabi Usa, Ipca Labs Ltd, Sagent Pharms, Hikma Farmaceutica, Amneal Pharms, Dr Reddys Labs Ltd, and Claris, and is included in eighty-four NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ondansetron has fourteen patent family members in ten countries.

There are twenty-eight drug master file entries for ondansetron. Thirty-seven suppliers are listed for this compound. There are three tentative approvals for this compound.

Summary for Generic Name: ondansetron

Tradenames:9
Patents:3
Applicants:42
NDAs:84
Drug Master File Entries: see list28
Suppliers / Packagers: see list37
Bulk Api Vendors: see list77
Clinical Trials: see list146
Patent Applications: see list7,447
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ondansetron at DailyMed

Pharmacology for Ingredient: ondansetron

Tentative approvals for ONDANSETRON

Applicant Application No. Strength Dosage Form
► Subscribe► SubscribeEQ 2MG BASE/MLINJECTABLE;INJECTION
► Subscribe► SubscribeEQ 2MG BASE/MLINJECTABLE;INJECTION
► Subscribe► Subscribe4MGTABLET, ORALLY DISINTEGRATING;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma
ONDANSETRON
ondansetron
TABLET, ORALLY DISINTEGRATING;ORAL090469-001Apr 12, 2010ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma
ONDANSETRON HYDROCHLORIDE
ondansetron hydrochloride
TABLET;ORAL078539-001Jul 31, 2007ABRXNoNo► Subscribe► Subscribe
Chartwell Molecules
ONDANSETRON HYDROCHLORIDE
ondansetron hydrochloride
TABLET;ORAL077303-004Jun 25, 2007DISCNNoNo► Subscribe► Subscribe
Mylan Labs Ltd
ONDANSETRON HYDROCHLORIDE
ondansetron hydrochloride
INJECTABLE;INJECTION078257-001Apr 23, 2008APRXNoNo► Subscribe► Subscribe
Aurobindo Pharma
ONDANSETRON
ondansetron
TABLET, ORALLY DISINTEGRATING;ORAL090469-002Apr 12, 2010ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Predict branded drug patent expiration
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot